TKI
Showing 1176 - 1196 of 1,196
Non Small Cell Lung Cancer, Adenocarcinoma Trial in Goyang-si (Gefitinib, Placebo, Pemetrexed plusCIsplatin)
Unknown status
- Non Small Cell Lung Cancer
- Adenocarcinoma
- Gefitinib
- +2 more
-
Goyang-si, Gyenggido, Korea, Republic ofNational Cancer Center
Jun 19, 2012
NSCLC Trial in Boston (Cetuximab)
Terminated
- Non-small Cell Lung Cancer
-
Boston, Massachusetts
- +2 more
Aug 2, 2012
Leukemia, Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in Houston (Interleukin-11 (IL-11 or Neumega))
Completed
- Leukemia
- +2 more
- Interleukin-11 (IL-11 or Neumega)
-
Houston, TexasUT MD Anderson Cancer Center
Feb 17, 2012
Lung Cancer, NSCLC Trial in Goyang-si (Erlotinib, Induction or consolidation IP chemo, CCRT with IP chemo (Irinotecan +
Unknown status
- Lung Cancer
- NSCLC
- Erlotinib
- +3 more
-
Goyang-si, Gyenggi-do, Korea, Republic ofNational Cancer Center, Korea
Nov 4, 2011
Tumors, Cancer, Tumors Trial in Glasgow, Sutton (CHIR-258 (TKI258))
Terminated
- Neoplasms
- +2 more
- CHIR-258 (TKI258)
-
Glasgow, United Kingdom
- +1 more
Jan 4, 2011
The Roles of Neutrophil Elastase in Lung Cancer
Unknown status
- Lung Cancer
- Chronic Obstructive Pulmonary Diseases
-
Hong Kong, Hong KongQueen Mary Hospital
May 27, 2011
Squamous Cell Carcinoma of Bronchus Trial in Seoul (Gefitinib)
Unknown status
- Squamous Cell Carcinoma of Bronchus
-
Seoul, Korea, Republic ofSeoul Veterans Hospital
Dec 5, 2011
Acute Myeloid Leukemia Trial in Houston (TKI258)
Terminated
- Acute Myeloid Leukemia
-
Houston, TexasThe University of Texas, M.D. Anderson Cancer Center
Jun 29, 2010
NSCLC Trial in Hangzhou (Prophylactic cranial irradiation, Erlotinib /Gefitinib)
Unknown status
- Non-small Cell Lung Cancer
- Prophylactic cranial irradiation
- Erlotinib /Gefitinib
-
Hangzhou, Zhejiang, China
- +1 more
Jul 6, 2010
NSCLC, Adenocarcinoma, Bronchiolo-Alveolar Trial in Seattle (VELCADE)
Terminated
- Carcinoma, Non-Small-Cell Lung
- Adenocarcinoma, Bronchiolo-Alveolar
-
Seattle, WashingtonSwedish Cancer Institute
Feb 16, 2011
Esophageal Cancer Trial in Hangzhou (gefitinib, Thoracic radiotherapy)
Unknown status
- Esophageal Cancer
- gefitinib
- Thoracic radiotherapy
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Feb 7, 2011
NSCLC Trial in Hangzhou (Erlotinib, Thoracic radiotherapy)
Unknown status
- Non-small Cell Lung Cancer
- Erlotinib
- Thoracic radiotherapy
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
May 13, 2010
Non-Small-Cell Lung Cancer Trial in Taipei City (UFUR and Iressa)
Completed
- Non-Small-Cell Lung Cancer
- UFUR and Iressa
-
Taipei City, TaiwanTaipei VGH
Dec 22, 2009
NSCLC Trial in Taipei (cancer cell lines establishment)
Unknown status
- NSCLC
- cancer cell lines establishment
-
Taipei, Taiwan
- +1 more
Nov 25, 2009
NSCLC Trial in Worldwide (BMS-275183 (oral taxane))
Terminated
- Non-small Cell Lung Cancer
- BMS-275183 (oral taxane)
-
Burlington, Massachusetts
- +29 more
Feb 27, 2010
NSCLC Trial in Tainan (erlotinib (Tarceva), pemetrexed (Alimta))
Unknown status
- Non-Small Cell Lung Cancer
- erlotinib (Tarceva)
- pemetrexed (Alimta)
-
Tainan, TaiwanNational Cheng-Kung University Hospital
May 15, 2009
NSCLC, Brain Metastasis Trial (gefitinib)
Unknown status
- Non-Small Cell Lung Cancer
- Brain Metastasis
- (no location specified)
Feb 13, 2008